Annuaire scientifique
Mme Aurore DUMOND
Doctorante - Équipe Mécanismes de Résistance aux Thérapies CibléesTel. +377 97 77 44 49
Email : [javascript protected email address]
Thèmes de recherche développés
Publications CSM
-
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas
Dumond A, Montemagno C, Vial V, Grépin R, Pagès G
Cells 10(5): 1222 -
Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
Dumond A, Brachet E, Durivault J, Vial V, Puszko A K, Lepelletier Y, Montemagno C, Pagnuzzi M, Hermine O, Garbay C, Lagarde N, Montes M, Demange L, Grépin R, Pagès G
J Exp Clinical Cancer Research 40: 33 -
Relevance of Neuropilin 1 and Neuropilin 2 targeting for cancer treatment
Dumond A, Pagès G
J Cancer Immunol 3(2): 111-114 -
Les neuropilines : Des cibles pertinentes pour améliorer le traitement des cancers
Dumond A, Demange L, Pagès G
Med Sci (Paris) 36(5): 487-496 -
Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral Microenvironment
Dumond A, Pagès G
Front Cell Dev Biol 8: 662 -
The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor
Grépin R, Guyot M, Dumond A, Durivault J, Ambrosetti D, Roussel J F, Dupré F, Quintens H, Pagès G
Theranostics 10(3): 1107-1121 -
Synthesis, 3D-structure and stability analyses of NRPa-308, a new promising anti-cancer agent
Brachet E, Dumond A, Liu W-Q, Fabre M, Selkti M, Raynaud F, Hermine O, Benhida R, Belmont P, Garbay C, Lepelletier Y, Ronco C, Pagès G, Demange L
Bioorg Med Chem Lett 29:126710